tiprankstipranks
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269

Compare Wuxi Biologics (Cayman) (2269) vs. Competitors

55 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Wuxi Biologics (Cayman)
HK$35.90
HK$148.55B
11.12
86.78%
11 Buy
1 Hold
0 Sell
Strong Buy
Genscript Biotech
HK$12.81
HK$27.88B
-6.48
27.59%
4 Buy
0 Hold
0 Sell
Strong Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$59.24B
18.63
73.93%
4 Buy
0 Hold
0 Sell
Strong Buy
Frontage Holdings Corp.
HK$1.03
HK$2.06B
16.78
-11.40%
Viva Biotech Holdings
HK$1.76
HK$4.12B
3.99
44.44%
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$24.51B
42.36
384.65%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2269
Wuxi Biologics (Cayman)
35.90
14.70
69.34%
HK:1548
Genscript Biotech
12.81
2.19
20.62%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
21.08
8.39
66.10%
HK:1521
Frontage Holdings Corp.
1.01
-0.16
-13.68%
HK:1873
Viva Biotech Holdings
1.95
0.50
34.48%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
60.00
47.72
388.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts